aid: ambagon-therapeutics

name: Ambagon Therapeutics

image: https://www.ambagontx.com/wp-content/uploads/2021/12/yoast-ambagontx.jpg

description: 'Ambagon Therapeutics is a biotechnology company focused on developing novel therapeutics targeting metabolic and inflammatory diseases. The company aims to leverage advanced drug discovery platforms and collaborations to bring innovative treatments to patients. While currently a stub in the API Evangelist network, further profiling will uncover its API offerings and documentation.'

url: https://raw.githubusercontent.com/api-evangelist/ambagon-therapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-05 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-09-24'

modified: '2026-09-24'

tags:
- Company
- Biotechnology
- Therapeutics
- Drug Discovery
- Metabolic Diseases

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/ambagon-therapeutics-hosts.yml
- type: Vendors
  url: vendors/ambagon-therapeutics-vendors.yml
- type: TermsOfService
  url: https://www.ambagontx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.ambagontx.com/privacy-policy/
- type: Newsroom
  url: https://www.ambagontx.com/news/
- type: DomainSecurity
  url: security/ambagon-therapeutics-domain-security.yml
- type: Website
  url: https://www.ambagontx.com/

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  detail: No developer program or API documentation is publicly available.
  evidence:
    - url: https://www.ambagontx.com/
      status: 200
  checked: '2026-10-05'
x-enrichment:
  date: '2026-10-05'
  status: enriched
  artifacts_added: 7
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local